Your browser doesn't support javascript.
loading
[Cuproptosis-related immune gene signature predicts clinical benefits from anti-PD-1/PD-L1 therapy in non-small-cell lung cancer.
Luo, Linfeng; Li, Anlin; Fu, Sha; Du, Wei; He, Li-Na; Zhang, Xuanye; Wang, Yixing; Zhou, Yixin; Yunpeng, Yang; Li, Zhang; Hong, Shaodong.
Afiliación
  • Luo L; State Key Laboratory of Oncology in South China, Guangzhou, China.
  • Li A; Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Fu S; Department of Medical Oncology, Sun Yat-Sen University Cancer Center, 651 Dongfeng East Road, Guangzhou, 510060, Guangdong, China.
  • Du W; State Key Laboratory of Oncology in South China, Guangzhou, China.
  • He LN; Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Zhang X; Department of Medical Oncology, Sun Yat-Sen University Cancer Center, 651 Dongfeng East Road, Guangzhou, 510060, Guangdong, China.
  • Wang Y; Department of Cellular & Molecular Diagnostics Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, China.
  • Zhou Y; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation of Sun Yat-Sen University, Guangzhou, 510120, China.
  • Yunpeng Y; State Key Laboratory of Oncology in South China, Guangzhou, China.
  • Li Z; Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Hong S; Department of Medical Oncology, Sun Yat-Sen University Cancer Center, 651 Dongfeng East Road, Guangzhou, 510060, Guangdong, China.
Immunol Res ; 71(2): 213-228, 2023 04.
Article en En | MEDLINE | ID: mdl-36434349

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Immunol Res Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2023 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Immunol Res Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2023 Tipo del documento: Article